KATHARINE PRICE, M.D.
Medical Oncology Physician · ROCHESTER, MN
Individual Active NPI 1093794075
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 500 | 91,918 | $8,219,076 | $2,702,276 | $2,150,948 |
| 2023 | 424 | 62,326 | $5,617,493 | $1,840,273 | $1,463,613 |
| 2022 | 397 | 60,143 | $5,075,876 | $1,708,946 | $1,362,902 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 11,400 | $53 | $42 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 9,546 | $50 | $40 |
| J1453 | Injection, fosaprepitant, 1 mg | 9,150 | $0 | $0 |
| J9267 | Injection, paclitaxel, 1 mg | 7,734 | $0 | $0 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 5,360 | $0 | $0 |
| J9299 | Injection, nivolumab, 1 mg | 4,200 | $31 | $25 |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | 2,700 | $13 | $11 |
| J9305 | Injection, pemetrexed, not otherwise specified, 10 mg | 1,870 | $4 | $4 |
| J9041 | Injection, bortezomib, 0.1 mg | 1,350 | $2 | $1 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,334 | $0 | $0 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 1,150 | $1 | $1 |
| Q5115 | Injection, rituximab-abbs, biosimilar, (truxima), 10 mg | 1,140 | $33 | $26 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | 46845 | MN |
| Internal Medicine Physician | 207R00000X | 46845 | MN |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Minnesota
- NPI 1437278959
- NPI 1003376468
- NPI 1982680583
- NPI 1801877501
- NPI 1437136553
- NPI 1417148180
- NPI 1306879028
- NPI 1265729834
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.